Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Albert

Colon & Rectal Surgery Altamonte Springs, FL Medical Doctor

NPI 1699729244 CMS profile 122203

661 E Altamonte Dr, Suite 220, Altamonte Springs, FL 32701

Open in the dashboard

General payments

$514,278

539 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$354,024

14 holdings reported · through program year 2025

Research they led as principal investigator

$341 paid to institutions, not to them · program year 2019

Through program year 2025, Matthew Albert of Altamonte Springs, FL is reported in the CMS Open Payments database as having received $514,278 across 539 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $341 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $354,024 across 14 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,788 82
2024 General $81,172 99
2023 General $103,387 94
2022 General $72,348 92
2021 General $44,654 42
2020 General $37,399 32
2019 General $110,529 98
2025 Ownership $58,468 2
2024 Ownership $58,468 2
2023 Ownership $59,540 2
2022 Ownership $59,540 2
2021 Ownership $39,634 2
2020 Ownership $39,634 2
2019 Ownership $38,740 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Albert
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Matthew Albert were reported at $64,788. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Matthew Albert Colon & Rectal Surgery median Middle half National median
2019 $110,529 $443 $125–$2,179 $163
2020 $37,399 $167 $53–$931 $114
2021 $44,654 $207 $72–$1,272 $132
2022 $72,348 $341 $111–$1,587 $149
2023 $103,387 $322 $115–$1,420 $160
2024 $81,172 $328 $112–$1,354 $164
2025 $64,788 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Applied Medical Resources Corporation $243,147 198 payments
  2. Stryker Corporation $189,553 154 payments
  3. Medtronic, Inc. $33,283 57 payments
  4. CONMED Corporation $20,248 21 payments
  5. Intuitive Surgical, Inc. $9,836 67 payments
  6. Ethicon US, LLC $8,451 7 payments
  7. CooperSurgical, Inc. $5,400 3 payments
  8. Covidien LP $1,162 4 payments
  9. Baxter Healthcare $975 3 payments
  10. THD America, Inc. $735 6 payments
  11. Other $1,488 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $352,198 126 payments
  2. Travel and Lodging $63,877 170 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,978 23 payments
  4. Honoraria $24,000 8 payments
  5. Food and Beverage $12,725 210 payments
  6. Education $3,500 2 payments
Products named General payments · program years 2019–2025
  1. SPY-PHI SYSTEM $77,520 56 payments
  2. Gelport Laparoscopic System $58,687 57 payments
  3. 1688 $37,995 16 payments
  4. SPY TECHNOLOGY $31,917 25 payments
  5. GELPOINT PATH $27,602 24 payments
  6. 1788 $23,694 19 payments
  7. AIM LAPARASCOPES $20,273 11 payments
  8. GelPOINT V-Path $15,800 9 payments
  9. AirSeal $15,303 6 payments
  10. Signia $14,749 38 payments
  11. Other $76,432 202 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$111,289

Medicare's payments for the services billed

Medicare patients

231

Average age 73

Services billed

548

106 women, 125 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Cancer 49%
Arthritis 46%
Ischemic heart disease 38%
Diabetes 35%
Chronic kidney disease 35%
Depression 24%
Heart failure 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

539 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record